Related Experiment Video
Updated: Aug 1, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Intensive blood pressure control for patients aged over 60: A meta-analysis of the SPRINT, STEP, and ACCORD BP
Xiaoting Li1, Jiejun Zhang1, Zhenhua Xing2
1Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China; Xiangya School of Medicine, Central South University, Changsha 410013, China.
Insights
Intensive blood pressure treatment in older adults lowered major adverse cardiovascular events and stroke risk but increased hypotension and syncope. Mortality and renal outcomes remained unchanged.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Clinical Trials
Background:
- Older adults (over 60 years) are at increased risk for cardiovascular disease (CVD).
- Determining optimal blood pressure (BP) targets in this demographic is crucial for effective CVD prevention.
- Previous studies have yielded mixed results on the benefits and risks of intensive BP lowering in the elderly.
Approach:
- A meta-analysis was conducted using individual-level data from the SPRINT, STEP, and ACCORD BP trials.
- Included 18,806 participants over 60 years of age, randomized to standard or intensive BP treatment.
- Hazard ratios (HRs) were calculated for major adverse cardiovascular events (MACEs), mortality, renal outcomes, and adverse events like hypotension and syncope.
Key Points:
- Intensive BP treatment significantly reduced the incidence of MACEs (HR: 0.83) and stroke (HR: 0.70).
- No significant reduction was observed in all-cause mortality (HR: 0.98) or cardiovascular mortality (HR: 0.77).
- The risk of hypotension (HR: 1.46) and syncope (HR: 1.43) was significantly increased.
Conclusions:
- Intensive BP lowering in adults over 60 reduces MACEs and stroke but elevates risks of hypotension and syncope.
- No significant impact on mortality or renal outcomes was found.
- These findings highlight a trade-off between benefits and risks for intensive BP management in older populations.
Objectives:
To evaluate the effects of intensive treatment to lower blood pressure (BP) on the risk of cardiovascular disease (CVD) among patients aged over 60 years.
Study Design:
We extracted individual-level data of participants aged over 60 years from the SPRINT study and ACCORD study first, and then conducted a meta-analysis of major adverse cardiovascular events (MACEs) and other adverse events (hypotension and syncope) and renal outcomes across the SPRINT, STEP, ACCORD BP trials, which included 18,806 participants over 60 years of age. Participants were randomized to receive standard BP treatment or intensive BP treatment.
Main Outcome Measures:
Hazard ratios (HRs) were used to calculate summary statistics.
Results:
In this meta-analysis, intensive treatment did not decrease either the all-cause mortality rate (HR: 0.98; 95 % confidence interval [CI]: 0.76-1.26; p = 0.87) or the cardiovascular mortality rate (HR: 0.77; 95 % CI: 0.54-1.08; p = 0.13). The incidence of MACEs (HR: 0.83; 95 % CI: 0.74-0.94; p = 0.003) and stroke (HR: 0.70; 95 % CI: 0.56-0.88; p = 0.002) was reduced, however. Intensive treatment had no effect on acute coronary syndrome (HR: 0.87; 95 % CI: 0.69-1.10; p = 0.24) or heart failure (HR: 0.70; 95 % CI: 0.40-1.22; p = 0.21). Intensive treatment increased the risk of hypotension (HR: 1.46; 95 % CI: 1.12-1.91; p = 0.006) and syncope (HR: 1.43; 95 % CI: 1.06-1.93; p = 0.02). Intensive treatment did not increase the risk of impaired kidney function among patients with chronic kidney disease (HR: 0.98; 95 % CI: 0.41-2.34; p = 0.96) or without chronic kidney disease (HR: 1.77; 95 % CI: 0.48-6.56; p = 0.40) at baseline.
Conclusions:
Intensive BP goals reduced the incidence of MACEs and increased the risk of other adverse events without significant changes in mortality or renal outcome.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
05:51Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Related Concept Videos
Assessment of blood pressure in brachial artery(two-step method)
Pre-Procedural Guidelines for Assessing Blood Pressure
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension III: Clinical Manifestations and Diagnostic Studies
Factors affecting Blood pressure
Physiological Factors: